drugset / Trial / NCT06364072
Safety, Tolerability, Analgesic Effect, and Feasibility of Intranasal CT001 in Pediatric Patients
NaSingle-groupOpen-labelTreatment
Summary
The proposed study aims to investigate the safety, tolerability, analgesic efficacy, and feasibility of intranasal sufentanil/ketamine (CT001) in pediatric participants attending an acute care (i.e. emergency) setting. The study is a part of the clinical development plan for the development of CT001 nasal spray for treatment of acute pain in children.
Timeline
- Start
- 2024-05-27
- Primary completion
- 2025-05-09
- Completion
- 2025-05-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | — | Intranasal |
| Subject | Sufentanil | Other / unclassified | — | Intranasal |
Indications
No indication recorded.